EUCTR2010-023233-30-NL
Active, not recruiting
Not Applicable
‘Intravenous iron treatment in iron deficient patients with pulmonary arterialhypertension' - Treating iron deficiency in PAH
VU university medical center0 sites30 target enrollmentOctober 6, 2010
DrugsFerinject
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- VU university medical center
- Enrollment
- 30
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Stable idiopathic pulmonary arterial hypertension (stable disease for at least 3 months)
- •\- iron deficiency (serum iron below 10 µmol/l, decreased transferrin saturation (\<15% in females and \<20% in males) and serum ferritin \<100 µg/l) irrespective of the coexistence of anaemia
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\- Current iron therapy (oral or iv)
- •\- Current other study medication for PAH
- •\- History of anaemia or current treatment of anaemia
- •\- Liver function impairment
- •\- Chronic disease other than PAH ( rheumatism, asthma, chronic infection)
- •\- Acute infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Intravenous iron for treatment of Sub-optimal iron stores in Non-Anaemic Patients presenting for major SurgeryIron deficiencyBlood - AnaemiaSurgery - Other surgeryACTRN12620000314921The University of Western Australia50
Active, not recruiting
Phase 1
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatioEUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
Active, not recruiting
Phase 1
Intravenous iron supplement for patients with severe aortic stenosis who have iron deficiencyIron deficiency, aortic stenosisMedDRA version: 20.0 Level: HLT Classification code 10022971 Term: Iron deficiencies System Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2019-002037-11-NOOslo University Hospital100
Active, not recruiting
Phase 1
TREAT STUDY : TREATMENT OF IRON DEFICIENCY ANAEMIA WITH TARDYFERON. Importance of prolonging iron supplementation in anemic women of childbearing age - TREAT STUDYIron Deficiency Anaemia is a common pathology which concerns less than 5% of women aged 15 to 49 years old in the western countries but can affect up to 30% of the world population, knowing that 9 to 10 anaemic patients live in developing countries. Treating at least 3 months allows to normalize haemoglobin but it is important to carry on the iron treatment in order to fully replenish the iron stores.EUCTR2006-003378-90-FRPIERRE FABRE MEDICAMENT
Not yet recruiting
Phase 3
Haem iron supplementation to combat iron deficiency and anaemia in African children - IDeA Study 3Nutritional, Metabolic, EndocrinePaediatricsPACTR202210523178727Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine208